Hospital system Scripps Health is using Quest Diagnostics' saliva test that screens for four genetic mutations found in patients who don't respond to Plavix, a blood thinner from Bristol-Myers Squibb and Sanofi-Aventis. Quest said the product yields results more quickly than others, and it plans to launch the test nationally later this month.

Full Story:

Related Summaries